NEO
NeoGenomics Inc
19.30$
-1.2%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 59.0% | 56.5% | 58.1% | 55.9% | 55.4% | 55.1% | 56.4% | 57.4% | 57.2% | 60.2% | 56.7% | 54.4% | 57.1% | |
| 41.0% | 43.5% | 41.9% | 44.1% | 44.6% | 44.9% | 43.6% | 42.6% | 42.8% | 39.8% | 43.3% | 45.6% | 42.9% | |
| 3.5% | 4.6% | 4.9% | 4.8% | 4.6% | 4.6% | 6.1% | 5.0% | 4.6% | 4.8% | 5.1% | 5.3% | 5.0% | |
| 40.5% | 38.4% | 42.1% | 38.5% | 39.9% | 37.0% | 38.8% | 39.6% | 37.2% | 33.4% | 35.2% | 31.5% | 34.3% | |
| 56.9% | 55.4% | 61.5% | 57.4% | 57.2% | 55.6% | 60.1% | 68.9% | 57.2% | 45.7% | 53.1% | 50.4% | 51.6% | |
| -15.9% | -11.9% | -19.6% | -13.3% | -12.6% | -10.7% | -16.6% | -26.3% | -14.4% | -5.9% | -9.8% | -4.8% | -8.6% | |
| 1.1% | 1.1% | 1.1% | 1.0% | 1.0% | 0.9% | 1.0% | 0.5% | 0.3% | 0.3% | 0.3% | 0.4% | 0.3% | |
| -14.1% | -9.8% | -17.7% | -11.6% | -10.6% | -9.4% | -15.3% | -25.3% | -14.1% | -6.5% | -9.4% | 0.9% | -7.1% | |
| -1.9% | -0.6% | -0.4% | -0.2% | -0.1% | -0.5% | 0.2% | -0.4% | 0.4% | -1.3% | -0.3% | -0.2% | -0.3% | |
| -12.2% | -9.2% | -17.3% | -11.3% | -10.5% | -8.9% | -15.4% | -24.9% | -14.4% | -5.2% | -9.2% | 1.1% | -6.8% | |
| -1.1% | 3.1% | -4.9% | 0.5% | 1.1% | 2.1% | -3.8% | -15.2% | -5.3% | 2.4% | -0.3% | 9.3% | 1.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.